The phase 2 trial is enrolling Fuchs dystrophy patients who are scheduled to undergo Descemet Stripping Only (DSO), also known as Descemetorhexis Without Endothelial Keratoplasty (DWEK).

CERA Research Fellow Dr Gink Yang is a passionate advocate for precision medicine in ophthalmology. He's been exploring how ...

Fuchs’ dystrophy affects the cornea, which is the transparent front tissue of the eye. The inner layer of cornea is covered ...

Fuchs explains that this research builds on the work of Judah Folkman and Rakesh Jain that looked at vascular endothelial ...